Advanced Oncotherapy – Director Dealing & Total Voting Rights

AVO1Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, has been informed that Michael Sinclair, Executive Chairman of the Company, has yesterday sold 7 million ordinary shares of 1 penny each in the Company at 8.25 pence per Share in order to fund the exercise of warrants over 28.5 million Shares at an exercise price of 1.1 pence per Share.

The remainder of the funds raised from Mr Sinclair’s share sale will be used to fund the acquisition of the option over 30 million Shares from Brahma A.G., which was announced of 4 June 2015.

Michael Sinclair’s resultant increased interest in the Company ordinary share capital is as follows:

Resultant holding

Shares held before the above transactions

Net increase as a result of the above transactions

Number of Shares

As a percentage of the enlarged share capital

Shares

 

68,079,757

21,500,000

89,579,757

6.5%

Options over Shares

65,800,000

65,800,000

na

Following these transactions Michael Sinclair does not hold any further warrants over Shares.

Application has been made for the 28,500,000 Warrant Shares to be admitted to trading on AIM and it is expected that Admission will occur on 7 July 2015. The Warrant Shares will rank pari passu in all respect with the existing Shares of the Company.

Total Voting Rights:

Following Admission, the Company’s enlarged issued share capital will comprise 1,376,422,626 Shares, with voting rights. The Company does not hold any Shares in treasury. Therefore the total number of Shares in the Company with voting rights will be 1,376,422,626. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.

For further information contact:

Advanced Oncotherapy Plc

www.avoplc.com

Sanjeev Pandya, CEO            

Tel: +44 20 3617 8728

Nicholas Serandour, CFO

Westhouse Securities (Nomad & Joint Broker)

Tel: +44 20 7601 6100

Antonio Bossi / David Coaten

Beaufort Securities (Joint Broker)

Tel: +44 20 7382 8300

Saif Janjua / Jon Levinson

Walbrook PR (Financial PR & IR)

Tel: +44 20 7933 8780 or avo@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 7980 541 893 / Mob: +44 7876 741 001

Advanced Oncotherapy – Bloomberg Business – RNCOS – Business Consultancy Services: US Proton Therapy Market Outlook 2020

AVO1Bloomberg Business – RNCOS – Business Consultancy Services: US Proton Therapy Market Outlook 2020.

M2 Communications

In light of an alarmingly rising incidence of cancers and limited treatment options, physicians are being forced to look beyond conventional treatments. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to a low number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients.

According to the “US Proton Therapy Market Outlook 2020″, report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will breach a Billion dollar mark to attain revenue of around US$ 1.22 Billion by 2020, growing at a CAGR of 11.4% during the forecast period (2014-2020).

Full Bloomberg Business article here

Sirius Minerals SXX Set to Soar After Planning Approval

SXXLast night Sirius’ planning application for a potash mine in the North Yorks Moors National Park, was finally given the go ahead after an all day hearing.  The planning committee’s approval brought to an end years of argument and tension as to whether the project was so exceptional that it should be allowed despite the fact that it is in one of the countries most loved National Parks.

This is not just any old potash mine. It is huge. It will create a thousand jobs in an area which is desperate for work. It is one of the worlds largest deposits of potash and all the production will be exported, helping to bring life back to  towns in the north east. For one project It will make a massive contribution to the UK’s balance of payments.

The decision by a majority of 8 – 7, was touch and go but it now means that the shares of Sirius, which were suspended yesterday morning, should be set to soar as soon as the suspension is lifted this morning, bringing to an end the long period of mixed doubt, despair and hope for the long suffering shareholders. Over the last few weeks the shares have declined from 24p to yesterdays pre suspension level 15.5p, as doubts grew about a successful out come for the application.

Looking for luxury villas and houses for sale in Greece -click here; http://www.hiddengreece.net

Feedback PLC – Dr Balaji Ganeshan talking at UK Radiological Congress 2015

FBKlogoDr. Balaji Ganeshan, Chief Scientist & New Business Officer at  Feedback PLC, (and group companies TexRAD and CCI Ltd) will be giving a talk entitled “Quantifying Tumour heterogeneity with TexRAD texture analysis on CT and MRI”

Where: at the Guerbet Laboratories Ltd stand at UK Radiological Congress 2015 in Liverpool, UK (30th June 4pm and 1st July 11am).

Full details of the conference can be found on the UKRC website here.

Attendees and delegates please register at the Guerbet stand.

Alan Green discusses Zambeef Products (ZAM) with Justin Waite on the ADVFN podcast

zambeefAlan Green discusses Zambeef Products (ZAM) with Justin Waite on the ADVFN podcast.

Click here to listen to the podcast.

Feedback (FDBK) – Total voting rights

FBKlogoFeedback plc announces in accordance with the FCA’s Disclosure and Transparency Rules that the issued share capital of the Company comprises 201,857,857 ordinary shares.

Shareholders should use 201,857,857 as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

For further information contact:

Feedback plc

Tel: 01954 718072

Simon Barrell / Trevor Brown / Tom Charlton

Sanlam Securities UK (Nominated Adviser and Joint Broker)

Tel: 020 7628 2200

Simon Clements / Virginia Bull

Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Lucy Williams / Duncan Vasey

CEB Resources (CEB) – Total voting rights

CEB ResourcesCEB Resources plc announces in accordance with the FCA’s Disclosure and Transparency Rules that the issued share capital of the Company comprises 718,147,303 ordinary shares.

Shareholders should use 718,147,303 as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

For further information, please contact:

CEB Resources plc

Cameron Pearce / Jeremy King

Tel: +44 (0) 1624 681250

Sanlam Securities UK Limited (Nomad and Joint Broker)

Lindsay Mair / Andrew Wagstaff

Tel: +44 (0) 207 628 2200

Peter House Corporate Finance Limited (Joint Broker)

Lucy Williams / Charles Goodfellow

Tel: +44 (0) 207 469 0930

Cornhill Capital (Joint Broker)

Nick Bealer

Advanced Oncotherapy – Result of AGM

AVO1Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

For further information contact:

Advanced Oncotherapy Plc

www.avoplc.com

Sanjeev Pandya, CEO

Tel: +44 20 3617 8728

Nicolas Serandour, CFO

Westhouse Securities (Nomad & Joint Broker)

Antonio Bossi / David Coaten

Tel: +44 20 7601 6100

Beaufort Securities (Joint Broker)

Saif Janjua / Jon Levinson

Tel: +44 20 7382 8300

Walbrook PR (Financial PR & IR)

Tel: +44 20 7933 8780 or avo@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 7980 541 893 / Mob: +44 7876 741 001

Alan Green discusses Smart Metering Systems (SMS) on the ADVFN podcast

Alan Green discusses Smart Metering Systems (SMS) with Justin Waite on the ADVFN podcast.

Click here to listen to the podcast.

Advanced Oncotherapy – Proton radiation zaps US wallets.

Proton radiation zaps US wallets.

By Melinda Beck

Six new proton-beam centres are set to start delivering state-ofthe-art radiation to cancer patients around the country by year’s end. Ten more are expected by 2018, bringing the US total to 30

Link here for full article